Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$10.37
+2.98%
Mkt Cap $733.43M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+44.6%
Consensus $15.00 vs current $10.37
NASDAQ·Healthcare·Biotechnology
$10.37
+2.98%
Mkt Cap $733.43M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+44.6%
Consensus $15.00 vs current $10.37